Back
Vaxcyte Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Buy
75
PCVX
Vaxcyte
Last Price:
74.60
Seasonality Move:
14.24%
Sell
30
ALNY
Alnylam Pharmaceuticals
Last Price:
149.30
Seasonality Move:
19.79%
Buy
75
Vaxcyte (PCVX)
is a Buy
Is Vaxcyte a Buy, Sell or Hold?
- The current Vaxcyte [PCVX] share price is $74.57. The Score for PCVX is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- PCVX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
- The current Alnylam Pharmaceuticals [ALNY] share price is $149.40. The Score for ALNY is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PCVX Stock Price Chart
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $149.40
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.
PCVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.07 | Buy |
| Relative Strength Index (14 RSI): | 72.34 | Buy |
| Chaikin Money Flow: | -239476 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (60.34 - 68.8) | Buy |
| Bollinger Bands (100): | (61.94 - 72.68) | Buy |
ALNY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.08 | Buy |
| Relative Strength Index (14 RSI): | 49.64 | Sell |
| Chaikin Money Flow: | -157058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (144.92 - 151.18) | Buy |
| Bollinger Bands (100): | (144.43 - 179.11) | Sell |
PCVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.03 | Buy |
| 20-day SMA: | 65.28 | Buy |
| 50-day SMA: | 65.85 | Buy |
| 200-day SMA: | 59.04 | Buy |
| 8-day EMA: | 70.18 | Buy |
| 20-day EMA: | 67.12 | Buy |
| 50-day EMA: | 66.25 | Buy |
| 200-day EMA: | 60.23 | Buy |
ALNY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 149.99 | Sell |
| 20-day SMA: | 148.6 | Buy |
| 50-day SMA: | 149.26 | Buy |
| 200-day SMA: | 169.18 | Sell |
| 8-day EMA: | 149.7 | Sell |
| 20-day EMA: | 149.44 | Sell |
| 50-day EMA: | 151.58 | Sell |
| 200-day EMA: | 167.28 | Sell |
Vaxcyte Earnings Growth & PCVX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.88 per share, and an increase next year of $0.04 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.14 per share, a decrease this year of $0.52 per share, and an increase next year of $1.84 per share.
Vaxcyte Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Alnylam Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||